orbifloxacin has been researched along with Pyoderma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katz, T; Kay-Mugford, PA; Ngoh, M; Simmons, R; Varma, KJ; Weingarten, AJ; White, A; Zolynas, R | 1 |
Etoré, F; Ganière, JP; Médaille, C | 1 |
Miller, WH; Peters, J; Scott, DW | 1 |
3 other study(ies) available for orbifloxacin and Pyoderma
Article | Year |
---|---|
Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Case-Control Studies; Chromatography, High Pressure Liquid; Ciprofloxacin; Dog Diseases; Dogs; Drug Administration Schedule; Female; Male; Pyoderma; Skin; Tissue Distribution; Treatment Outcome | 2002 |
In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Otitis Externa; Pyoderma; Staphylococcal Skin Infections; Staphylococcus | 2004 |
Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dog Diseases; Dogs; Female; Male; Pyoderma; Staphylococcal Infections; Time Factors; Treatment Outcome | 2006 |